羧基化氧化石墨烯的血液相容性

氧化石墨烯的官能团修饰可促进氧化石墨烯与生物体液、聚合物基体等不同环境的融合. 通过超声法制备了氧化石墨烯, 并利用化学改性的方法, 将氧化石墨烯表面的羟基和环氧基转变为羧基. 红外图谱上羧基化氧化石墨烯(GeneO-COOH)的羧基振动明显, 峰强增大. GeneO-COOH的主要失重表现为羧基官能团缩合以一个水分子的形态释放失去结构水[OH2]. 复钙动力学曲线随着GeneO-COOH的浓度增加, 曲线上升趋势由陡峭趋于平缓, 当浓度为1.25 μg/mL时复钙时间延长了11 min, 平台期OD值降低了8.14 %; 在0.5~100 μg/mL浓度范围内溶血率均<5 %. GeneO-COOH比GeneO在同等低浓度下的抗凝血性能有一定程度的改善, 主要是因为带负电的羧基可直接络合凝血因子. 因此, 羧基修饰氧化石墨烯是提高血液相容性的有效手段, 羧基化氧化石墨烯可作为潜在的生物医用材料的填料.     

巯基化石墨烯对水中Pb(Ⅱ)的吸附性能研究

采用改进的Hummers法制备氧化石墨烯,在交联剂EDC作用下,巯基乙胺与氧化石墨烯上的羧基进行缩合反应,合成巯基化石墨烯。运用FTIR、SEM及XPS等手段对合成材料进行表征,结果表明,巯基乙胺成功接枝在氧化石墨烯表面。将巯基化石墨烯用于吸附去除水中的Pb(Ⅱ),结果表明,合成的巯基化石墨烯对Pb(Ⅱ)的吸附效果好,吸附量高达205.25mg/g。吸附动力学遵循准二级模型,且等温吸附数据可用Langmuir吸附等温线很好地拟合。本文报道的巯基化石墨烯对废水处理和净化有很大的潜在应用。     

羧基化氧化石墨烯的可控合成及血液相容性

采用自由基引发剂偶氮二异丁腈(AIBN)作为功能改性剂, 通过AIBN分解产生的异丁腈自由基进攻氧化石墨烯上五元环与七元环的缺陷点, 形成氰基改性氧化石墨烯中间体, 再通过水解反应制得羧基化氧化石墨烯[GeneO-C(CH₃)₂-COOH]纳米材料. 采用傅里叶变换红外光谱(FTIR), X射线衍射(XRD), 热重分析(TGA)和原子力显微镜(AFM)等方法对合成的材料进行了表征, 并采用复钙时间测试考察了材料的血液相容性. 研究结果表明, 氧化石墨烯中羧基的含量可以通过调整AIBN和GeneO的投料比来控制. 本方法不但可提高氧化石墨烯的羧基含量, 而且可使其具有良好的血液相容性.     

氧化石墨烯在仿生合成中的应用及研究

氧化石墨烯薄片的边缘含有大量的含氧功能团(如羧基等),这些官能团可以有效地与金属离子作用而成为晶体的成核位点,从而使得氧化石墨烯具备模板功能而用于仿生合成。论文综述了氧化石墨烯用作模板剂在仿生合成有机/无机杂化材料方面的应用研究进展,介绍了其基本原理,阐述了不同类型杂化材料的制备方法,并展望了石墨烯基有机/无机杂化材料的发展新趋势。     

一种新型枝化聚乙二醇的合成

以谷氨酸作为中心分子,首先对谷氨酸的氨基进行Boc保护,然后在4-二甲基氨基吡啶-二环己基碳二亚胺催化体系的作用下,将两条线性的单甲氧基聚乙二醇(mPEG)链连接到谷氨酸的两个羧基上,合成出含有两条聚乙二醇(PEG)链及一个活性氨基的新型枝化PEG[Glu(PEG)2],其结构经1H NMR,IR,GPC和VPO表征。     

氧化程度对氧化石墨烯a-b轴结构及电学性能的影响

采用改进的Hummers法及超声分散等后续处理制备不同氧化程度的氧化石墨烯样品。用XPS、XRD、AFM、UV-Vis及四探针测试仪对样品官能团变化规律、结构、形貌特征以及电学性能进行表征分析。结果表明,氧化石墨烯在超声波的作用下水相条件下可达单层分散,单层氧化石墨烯厚度约为1.4 nm:成膜过程中,在氢键力的作用下氧化石墨烯片层沿c轴重叠形成层状凝聚体,结构有序度较好;随氧化剂(KMn O4)用量增加,碳层平面上含氧官能团含量持续增加,特别是羟基官能团(C-OH)含量的增加,使a-b轴方向最大底面间距(d100和d110)一直增大,直至KMn O4用量达4.0 g时,部分C-OH水解,导致d100与d110略有减小;碳层平面上含氧官能团尤其是环氧官能团(C-O-C)含量的增加,使样品带隙宽度逐渐增大,导电性能越来越差。     

基于石墨烯纳米酶效应的谷胱甘肽含量的测定

利用羧基化氧化石墨烯(GO-COOH)的纳米酶效应,建立了一种谷胱甘肽制剂比色法含量测定方法。对反应时间、pH、H_2O_2浓度进行了优化。在最优条件下,谷胱甘肽标准品检测的线性范围为1～50μmol/L。将该方法用于谷胱甘肽片的含量测定,并采用液相色谱法对测定结果进行了验证,结果显示,谷胱甘肽片剂测定的相对误差为1. 8%。该方法简单、直观,可用于谷胱甘肽制剂含量的准确测定。     

功能化氧化石墨烯的细胞相容性

采用改进的Hummers方法制备了纳米尺度的氧化石墨烯.对氧化石墨烯的表面进行羧基化,并连接上聚乙二醇(PEG)使其在细胞培养液中可溶并能稳定保存.采用透射电镜(TEM)、傅里叶变换红外(FTIR)光谱和zeta电位测量等对修饰后的氧化石墨烯的结构和功能进行了表征.体外细胞实验表明PEG修饰的氧化石墨烯在水中具有良好的可溶性,对A549细胞没有明显的毒性,在生物医药领域具有潜在的应用价值.     

还原氧化石墨烯/TiO2纳米复合物制备及其光催化性能

采用一步水热法制备了还原氧化石墨烯-二氧化钛(RGO-P25)纳米复合物.通过透射电子显微镜(TEM)、傅里叶变换红外(FTIR)光谱、X射线光电子能谱(XPS)、X射线衍射(XRD)及紫外-可见漫反射谱(UVVisDRS)对复合材料的结构和光电性能进行了表征.在紫外光照和可见光照条件下,研究了不同复合比例的复合物的光催化降解甲基蓝(MB)的性能.结果表明:在水热过程中氧化石墨烯被还原,通过静电引力相互作用得到了具有较高缺陷的还原氧化石墨烯复合物.随着RGO含量的增加,复合物的禁带宽度由3.00 eV变到2.27eV,复合物的导电性增强.在可见光和紫外光光照条件下, 30 min内1%(w,质量分数)RGO-P25光催化降解甲基蓝的效率都超过了80%.紫外光照条件下, 1%RGO-P25纳米复合物催化降解N3染料, cis-Ru(H₂dcbpy)₂(NCS)₂ (H₂dcbpy = 4, 4'-二羧酸-2, 2'-联吡啶), 30 min内63%(摩尔分数)的染料被降解.与P25(75%锐钛矿, 25%金红石)相比,石墨烯的加入大大提高了光催化效率,有效抑制了电子-空穴对的复合.     

KH-570功能化石墨烯的制备与表征

采用Hummers法对天然石墨进行氧化处理制备了氧化石墨烯,通过γ-甲基丙烯酰氧丙基三甲氧基硅烷与氧化石墨烯反应得到功能化氧化石墨烯,然后在水合肼的作用下制备了功能化石墨烯。未烘干的功能化石墨烯在超声处理下,能稳定分散在体积比为9∶1(V/V)的乙醇/水、丙酮/水或N,N-二甲基甲酰胺/水的混合溶剂中。用傅立叶变换红外光谱、原子力显微镜、X射线光电子能谱及X射线衍射对样品结构、形貌进行了分析。结果表明,KH-570上的硅氧烷与氧化石墨烯上的羟基发生了反应,经水合肼还原后,功能化石墨烯的无序度增加,层间距也比功能化氧化石墨烯的缩小了。功能化石墨烯在DMF/水中呈高度剥离状态,片层厚度为1.1～2.3 nm。     

Synthesis and characterization of poly(2‐methacryloyloxyethyl phosphorylcholine) onto graphene oxide

The polyzwitterionic brushes comprised of poly(2‐methacryloyloxyethyl phosphorylcholine) (pMPC) segments, which are used for surface modification of polymers and biocompatible coatings, were investigated. In this work, reverse surface‐initiated atom transfer radical polymerization (RATRP) of zwitterionic 2‐methacryloyloxyethyl phosphorylcholine (MPC) is employed to tailor the functionality of graphene oxide (GeneO) in a well‐controlled manner and produce a series of well‐defined hemocompatible hybrids (termed as GeneO‐g‐pMPC). The complexes were characterized by FT‐IR, XRD, and Raman. Results show that MPC has been coordinated on the graphene oxide sheet. Thermal stability of the nanocomposites in comparison with the neat copolymer is revealed by thermogravimetric analysis and differential thermal analysis. Scanning electron microscopy and transmission electron microscope images of the nanoconposite displays pMPC chains were capable of existing on GeneO sheet by RATRP. The biocompatibility properties were measured by plasma recalcification profile tests, hemolysis test, and MTT assays, respectively. The results confirm that the pMPC grafting can substantially enhance the hemocompatibility of the GeneO particles, and the GeneO‐g‐pMPC hybrids can be used as biomaterials without causing any hemolysis. With the versatility of RATRP and the excellent hemocompatibility of zwitterionic polymer chains, the GeneO‐g‐pMPC nanoparticles with desirable blood properties can be readily tailored to cater to various biomedical applications. Copyright © 2013 John Wiley & Sons, Ltd.     

Graphene-Based Antimicrobial Biomedical Surfaces

Biomedical application of graphene derivatives have been intensively studied in last decade. With the exceptional structural, thermal, electrical, and mechanical properties, these materials have attracted immense attention of biomedical scientists to utilize graphene derivatives in biomedical devices to improve their performance or to achieve desired functions. Surfaces of graphene derivatives including graphite, graphene, graphene oxide and reduce graphene oxide have been demonstrated to pave an excellent platform for antimicrobial behavior, enhanced biocompatibility, tissue engineering, biosensors and drug delivery. This review focuses on the recent advancement in the research of biomedical devices with the coatings or highly structured polymer nanocomposite surfaces of graphene derivatives for antimicrobial activity and sterile surfaces comprising an entirely new class of antibacterial materials. Overall, we aim to highlight on the potential of these materials, current understanding and knowledge gap in the antimicrobial behavior and biocompatibility to be utilized of their coatings to prevent the cross infections.     

Selective Removal of Hydroxyl Groups from Graphene Oxide

Graphene has a wide range of potential applications, thus tremendous efforts have been put into ensuring that the most direct and effective methods for its large‐scale production are developed. The formation of graphene materials from graphene oxide through a chemical reduction method is still one of the most preferred routes. Numerous methods starting from various reducing agents have been developed to obtain near‐pristine graphene sheets. However, most of the reducing agents are not mechanistically supported by classical organic chemistry knowledge and of those that are supported, they are only theoretically capable of, at most, reducing oxygen‐containing groups on graphene oxide to hydroxyl groups. Herein, we present a mechanistically proven method for the selective defunctionalisation of hydroxyl groups from graphene oxide that is based on ethanethiol–aluminium chloride complexes and provides a graphene material with improved properties. The structural, morphological and electrochemical properties of the graphene materials have been fully characterised based on high‐resolution X‐ray photoelectron spectroscopy, Fourier transform infrared spectroscopy, Raman spectroscopy, scanning electron microscopy, electrochemical impedance spectroscopy and cyclic voltammetry techniques. Our analyses showed that the obtained graphene materials exhibited high heterogeneous electron‐transfer rates, low charge‐transfer resistance and high conductivity as compared to the parent graphene oxide. Moreover, the selective defunctionalisation of hydroxyl groups could potentially allow for the tailoring of graphene properties for various applications.     

Synthesis and characterization of graphene oxide‐based hybrid ligand and its metal complexes: Highly efficient sensor and catalytic properties

A new graphene oxide‐based hybrid material (HL) and its Co(II), Cu(II) and Ni(II) metal complexes were prepared. Firstly, graphene oxide and (3‐aminopropyl)trimethoxysilane were reacted to give graphene oxide–3‐(aminopropyl)trimethoxysilane (GO‐APTMS) hybrid material. After that, hybrid material HL was synthesized from the reaction of GO‐APTMS and 2,6‐diformyl‐4‐methylphenol. Finally, Co(II), Cu(II) and Ni(II) complexes of HL were obtained. All the materials were characterized using various techniques. The chemosensor properties of HL were investigated against Na⁺, K⁺, Cd²⁺, Co²⁺, Cu²⁺, Hg²⁺, Ni²⁺, Zn²⁺, Al³⁺, Cr³⁺, Fe³⁺ and Mn³⁺ ions and it was found that HL has selective chemosensing to Fe³⁺ ion. All the graphene oxide‐supported complexes were used as heterogeneous catalysts in the oxidation of 2‐methylnaphthalene (2MN) to 2‐methyl‐1,4‐naphthoquinone (vitamin K₃, menadione) in the presence of hydrogen peroxide, acetic acid and sulfuric acid. The Cu(II) complex showed good catalytic properties compared to the literature. The selectivity of 2MN to vitamin K₃ was 60.23% with 99.75% conversion using the Cu(II) complex.     

Improvement of hemocompatibility of polycaprolactone film surfaces with zwitterionic polymer brushes

Polycaprolactone (PCL) has been widely adopted as a scaffold biomaterial, but further improvement of the hemocompatibility of a PCL film surface is still needed for wide biomedical applications. In this work, the PCL film surface was functionalized with zwitterionic poly(3-dimethyl(methacryloyloxyethyl) ammonium propane sulfonate) (P(DMAPS)) brushes via surface-initiated atom transfer radical polymerization (ATRP) for enhancing hemocompatibility. Kinetics study revealed an approximately linear increase in graft yield of the functional P(DMAPS) brushes with polymerization time. The blood compatibilities of the modified PCL film surfaces were studied by platelet adhesion tests of platelet-rich plasma and human whole blood, hemolysis assay, and plasma recalcification time (PRT) assay. The improvement of hemocompatibility is dependent on the coverage of the grafted P(DMAPS) brushes on the PCL film. Lower or no platelet and blood cell adhesion was observed on the P(DMAPS)-grafted film surfaces. The P(DMAPS) grafting can further decrease hemolysis and enhance the PRT of the PCL surface. With the versatility of surface-initiated ATRP and the excellent hemocompatibility of zwitterionic polymer brushes, PCL films with desirable blood properties can be readily tailored to cater to various biomedical applications.     

Magnetic graphene oxide modified by imidazole‐based ionic liquids for the magnetic‐based solid‐phase extraction of polysaccharides from brown alga

Magnetic graphene oxide was modified by four imidazole‐based ionic liquids to synthesize materials for the extraction of polysaccharides by magnetic solid‐phase extraction. Fucoidan and laminarin were chosen as the representative polysaccharides owing to their excellent pharmaceutical value and availability. Fourier transform infrared spectroscopy, field‐emission scanning electron microscopy, and thermogravimetric analysis were applied to characterize the synthesized materials. Single‐factor experiments showed that the extraction efficiency of polysaccharides was affected by the amount of ionic liquids for modification, solid–liquid ratio of brown alga and ethanol, the stirring time of brown alga and ionic liquid‐modified magnetic graphene oxide materials, and amount of 1‐(3‐aminopropyl)imidazole chloride modified magnetic graphene oxide materials added to the brown alga sample solution. The results indicated that 1‐(3‐aminopropyl)imidazole chloride modified magnetic graphene oxide possessed better extraction ability than graphene oxide, magnetic graphene oxide, and other three ionic‐liquid‐modified magnetic graphene oxide materials. The highest extraction recoveries of fucoidan and laminarin extracted by 1‐(3‐aminopropyl)imidazole chloride modified magnetic graphene oxide were 93.3 and 87.2%, respectively. In addition, solid materials could be separated and reused easily owing to their magnetic properties.     

L-谷氨酸桥联的卟啉二联体的合成和表征及其CD光谱研究

通过L-谷氨酸(乙酰基保护)与二氯亚砜反应制备的二酰氯和单羟基卟啉(M-PH₂)反应,合成了L-谷氨酸桥联的卟啉二联体,用红外光谱、 电子吸收光谱、 核磁共振氢谱、 元素分析和质谱对化合物的结构加以确证,通过圆二色谱(CD)研究了化合物的手性特征.     

Alginate Bioconjugate and Graphene Oxide in Multifunctional Hydrogels for Versatile Biomedical Applications

In this work, we combined electrically-conductive graphene oxide and a sodium alginate-caffeic acid conjugate, acting as a functional element, in an acrylate hydrogel network to obtain multifunctional materials designed to perform multiple tasks in biomedical research. The hybrid material was found to be well tolerated by human fibroblast lung cells (MRC-5) (viability higher than 94%) and able to modify its swelling properties upon application of an external electric field. Release experiments performed using lysozyme as the model drug, showed a pH and electro-responsive behavior, with higher release amounts and rated in physiological vs. acidic pH. Finally, the retainment of the antioxidant properties of caffeic acid upon conjugation and polymerization processes (Trolox equivalent antioxidant capacity values of 1.77 and 1.48, respectively) was used to quench the effect of hydrogen peroxide in a hydrogel-assisted lysozyme crystallization procedure.